Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2026 Jun 24;148(26):27528–27539. doi: 10.1021/jacs.6c06046

Reversible Nucleolar Complex Coacervation by Short Cationic Peptides

Maximilian Schuler †,, Emirhan Koca †,, Leon Driehaus-Ortiz , Marius G Braun , Albin Lahu , Anna-Lena Holtmannspötter §, Ha-Chi Nguyen , Job Boekhoven ‡,§, David Y W Ng †,*, Tanja Weil †,‡,*
PMCID: PMC13352621  PMID: 42339573

Abstract

Biomolecular condensates formed through liquid–liquid phase separation play central roles in intracellular organization and regulation. Replicating such dynamic compartmentalization using minimal synthetic components remains exceptionally challenging inside living cells. Here, we report short cationic peptides that undergo directed complex coacervation in living cells through preferential interactions with endogenous polyanionic biomolecules. Although the peptides were designed to contain a mitochondrial targeting motif, the Arg residues and cellular RNA guide the supramolecular interactions toward selective enrichment of liquid-like coacervates in nucleolar regions. In vitro studies reveal that polymeric RNA mimics promote coacervation far more efficiently than ATP, establishing RNA–peptide interactions as the principal driving force. In cells, nucleolar complex coacervates form rapidly and exhibit liquid-like behavior with fast molecular exchange. Importantly, the assemblies are transient and reversible: sustained peptide supply maintains the condensed state, whereas substrate depletion triggers droplet dissolution and recovery of cellular function. These findings demonstrate that endogenous biopolymer distributions can guide and participate in the formation of synthetic coacervates with minimalistic peptides, achieving reversible reorganization of intracellular components. More broadly, this work provides a framework for engineering synthetic coacervates with nonequilibrium, life-like features that operate in direct exchange with living cellular environments.


graphic file with name ja6c06046_0009.jpg


graphic file with name ja6c06046_0007.jpg

Introduction

Biomolecular condensates formed through liquid–liquid phase separation organize intracellular chemistry without membranes, enabling dynamic control over molecular localization, reaction rates, and cellular signaling. These membrane-less compartments emerge in defined subcellular regions, including stress granules in the cytoplasm and nucleoli in the nucleus, where they regulate processes ranging from stress response to RNA metabolism to ribosome biogenesis. , Inspired by these dynamic cellular assemblies, substantial efforts have focused on engineering synthetic condensates inside living cells. However, achieving intracellular phase separation using minimal synthetic building blocks that engage and integrate endogenous cellular components remains a major challenge.

At the material–biology interface, intracellular self-assembly (ISA) promoted by rationally designed self-assembling peptides has emerged as a powerful method for generating nanostructures inside living cells. Following cellular entry in their monomeric form, endogenous triggers activate monomer precursors and initiate their assembly into polymers. The diverse intracellular microenvironments act as stimulus reservoirs (including pH, ROS, glutathione, and enzymes), spatially controlling the respective supramolecular chemistry within a specific location to form aggregates, nanofibers, and hydrogels, with applications ranging from programmed cellular death to stimulation of cytotoxic T cells. , Despite these advances, extending the ISA strategy from liquid–solid to liquid–liquid phase transitions remains largely unexplored due to significant conceptual and practical challenges. Reaching the critical concentration for liquid–liquid phase separation (LLPS) is particularly demanding, as it necessitates local peptide monomer concentrations that often exceed those required for designed liquid-to-solid phase transitions by at least 1 order of magnitude. Moreover, the dynamic nature of these droplets renders them inherently delicate, as environmentally sensitive interactions can readily be disrupted by variations in salt concentration, pH, or temperature. Consequently, the design of complex coacervates demands high-affinity interactions, a constant flux of the scaffold material, and robust stability, requirements that are especially critical in the cellular context, where environmental properties fluctuate in both time and space. , Owing to these practical limitations, peptide-based coacervates have so far been employed primarily in their preformed state, either as drug delivery vehicles or as artificial catalytic compartments. ,− Recent advances in engineered biomolecular condensates in living cells have enabled programmable sequestration, intracellular control, and de novo condensate design, yet these systems have largely relied on proteins or preorganized scaffolds rather than in situ complex coacervation of short synthetic peptides with endogenous cellular components. ,,

However, without forming these coacervates in situ, the dynamic and adaptive behavior characteristic of natural condensates cannot be directly accessed or interrogated within the full complexity of the cellular environment. Initiated by RNA–protein interactions, P granules, for instance, undergo multiple assembly and disassembly cycles during cell division, which is indispensable for symmetry-breaking events in C. elegans model systems. Inspired by this conceptual complexity, the substrate-induced complex coacervation strategy introduced here offers new opportunities to actively interact with cellular states and metabolism. By establishing dynamic intracellular reservoirs that assemble and dissipate in response to substrate availability, such systems could enable reversible modulation of intracellular function. In this context, developing a synergistic framework that integrates synthetic and natural matter under nonequilibrium conditions provides a missing link between systems chemistry and cell-responsive biomaterials.

Here, we demonstrate that short cationic peptides can exploit endogenous RNA-rich environments to form nucleolar complex coacervates in living cells, revealing a targeting principle governed by intracellular biopolymer distributions rather than solely by installed organelle-targeting motifs. These peptides serve as structural substrates that form complex coacervates in situ within living cells within 1 min. By correlating in vitro and in vivo data, we identify RNA affinity and the peptide’s Arg-content in the cellular context as key determinants of subcellular localization. Notably, under substrate-rich conditions, cells transiently maintain a dynamic regime in which droplet persistence reflects the continuous interplay between assembly and dissipation. Upon prolonged exposure, however, cells fail to sustain this state due to mitochondrial dysfunction and cell membrane permeabilization at the onset of apoptosis. In contrast, under substrate-depleted conditions, the deactivation pathway mediated by cellular expulsion of the substrate is sufficient to promote compound clearance and enable cellular recovery. This reversibility contrasts sharply with thermodynamically controlled, aggregate-based systems and highlights the nonequilibrium, life-like nature of the installed complex coacervates. Collectively, these findings establish ISA as a novel design principle for the nonequilibrium formation of coacervates at the interface of materials and biology, with both therapeutic and fundamental implications.

Results and Discussion

Peptide Design, Synthesis, and Purification

We designed a short cationic peptide Fmoc-K­(TPP)­RGRGR-CONH2 (Fmoc-R TPP ) with TPP (triphenyl phosphonium) introduced to promote mitochondrial targeting (Figure ). Arg residues were selected because their guanidino groups provide positive charges under physiological conditions, thereby enabling charge–charge and cation–π interactions with multivalent counterions such as ATP or nucleic acids. Three Arg residues were employed as previous studies in pristine systems have demonstrated their strong tendency to form complex coacervates in the presence of suitable counterions. Alternating Arg with Gly residues mimics the RG motifs commonly observed in phase-separating RNA-binding proteins. Ultimately, the N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) group restricts rotational freedom, engages in cation–π interactions, and serves as a hydrophobic π-block that stabilizes droplets under high salt concentration. To facilitate fluorescence imaging, the Coumarin-343 derivative Coumarin-K­(TPP)­RGRGR-CONH2 (Coum-R 3 TPP ) was additionally employed (Figure ). The peptides were synthesized by standard Fmoc-based solid-phase-peptide-synthesis (SPPS). TPP was coupled to the resin by selective side-chain deprotection of the labile 4-methyltrityl protecting group on Lys ε-NH2 (Scheme S1). All peptides were purified by reversed-phase high-performance liquid chromatography (HPLC), and their purity was confirmed by liquid chromatography mass spectrometry (LCMS) (Figure S1a–d).

1.

1

Conceptual framework for intracellular complex coacervation induced by short cationic peptides. In vitro, cationic pro-assembling peptides bearing different N-terminal modifications undergo liquid–liquid phase separation through charge–charge interactions with negatively charged cellular mimics such as polyU (RNA mimic) or ATP. In cellulo, soluble peptide monomers first enter the cell and subsequently accumulate in the nucleolus, where complex coacervation occurs through interactions with endogenous RNA. Under peptide-abundant conditions, nucleolar droplets persist dynamically before prolonged exposure leads to metabolic dysfunction and apoptotic cell death. In contrast, upon peptide depletion (e.g., medium exchange), complex coacervates dissolve and cellular morphology and viability recover. This schematic illustrates how intracellular peptide influx and removal regulate reversible phase separation in living cells.

LLPS through Complex Coacervation In Vitro

We anticipated that the addition of Fmoc-R 3 TPP to either ATP or polyuridylic acid (polyU) would lead to complex coacervation in vitro. Indeed, mixing Fmoc- R 3 TPP with either of these counterions produced a macroscopic increase in turbidity under neutral aqueous conditions (Dulbecco’s phosphate-buffered saline (DPBS) buffer, pH 7.4) (Figures a,b and S2). The presence of both constituents (Fmoc-R 3 TPP and either ATP or polyU) was required to induce turbidity, thereby excluding homocoacervation (Figure S3).

2.

2

In vitro complex coacervation of Fmoc-R 3 TPP with multivalent counterions. (a) Schematic illustration of complex coacervation between the cationic peptide Fmoc-R 3 TPP and polyanionic counterions. (b) Macroscopic turbidity observed upon mixing Fmoc-R 3 TPP with polyU; [Fmoc-R 3 TPP ] = 250 μM, [polyU] = 1 mM. (c) Turbidity phase diagram showing droplet formation as a function of peptide and polyU concentration (optical density at 600 nm). As representative data points, mean values of n = 3 replicas are presented. (d) Isothermal titration calorimetry (ITC) profiles of Fmoc-R 3 TPP interacting with polyU. Molar ratios are normalized to charges. Three curves correspond to n = 3 replicas. (e) Dissociation constants (KD) derived from ITC measurements showing substantially stronger binding to polyU compared to ATP. Error bars represent mean ± s.d. from n = 3 replicas. (f) Time-dependent CLSM images showing time-dependent coalescence of droplets formed by Fmoc-R 3 TPP (230 μΜ), Coum-R 3 TPP (20 μM), and polyU (1 mM). (g) Left: fluorescence recovery after photobleaching (FRAP) demonstrating liquid-like dynamics of the droplets. Right: normalized fluorescence recovery curve (mean ± s.d. from n = 3 replicas) for Fmoc-R 3 TPP (230 μM), Coum-R 3 TPP (20 μM), polyU (1 mM). All experiments were conducted in DPBS buffer, pH 7.4.

Expectedly, polyU exhibited a stronger tendency toward droplet formation than ATP as a polyanion. Whereas at least 1.5 mM Fmoc-R 3 TPP was required to induce droplet formation in the presence of 4 mM ATP, only 0.05 mM peptide was sufficient in the presence of 250 μM polyU (Figures c and S4). To probe the relative interaction strengths of ATP + Fmoc-R 3 TPP and polyU + Fmoc-R 3 TPP , the stability of the resulting droplets upon dilution with DPBS or acetonitrile was assessed. While droplets formed by polyU + Fmoc-R 3 TPP resisted dilution (up to 1:2 v/v), those formed by ATP + Fmoc-R 3 TPP readily dissolved (Figure S5a,b). A fluorescent centrifugation-based pull-down assay was performed to quantify the partitioning of Coum-R 3 TPP into droplets formed with polyU or ATP in the presence of Fmoc-R 3 TPP . Supplementation of Fmoc-R 3 TPP with 8 vol % of Coum-R 3 TPP did not measurably affect its coacervation behavior (Figure S5c). Because droplets formed by Fmoc-R 3 TPP and ATP were insufficiently stable to be pelleted upon centrifugation (16.2k g), Fmoc-R 3 TPP was approximately 47-fold more likely to partition into droplets formed by polyU (Figure S5d).

Isothermal titration calorimetry (ITC) further substantiated these findings when Fmoc-R 3 TPP was titrated against polyU or ATP (Figures d and S6a). While Fmoc-R 3 TPP showed only weak interactions with ATP, the dissociation constant (K D) was more than 2 orders of magnitude lower for polyU (K D = 3.5 ± 0.3 μM) (Figure e). The reaction enthalpy (ΔH) was approximately 9-fold higher for polyU (Figure S6b). Moreover, the data revealed a close to equimolar stoichiometry (calculated per charge) for polyU (N = 1.1 ± 0.1), which could not be reliably determined for ATP due to a weak signal (Figure S6c). Together, these data identify polyU as the superior counterion in terms of both affinity and stability, which together promote complex coacervation. This observation is consistent with previous reports in which RNA, as a competitive binder, effectively displaced ATP because of its higher charge valency.

To study the dynamics in complex coacervates formed by Fmoc-R 3 TPP and polyU, confocal laser scanning microscopy (CLSM) was performed using an in-house-built microreactor as described previously. Complex coacervates formed instantaneously, followed by coalescence over time (Figure f, Movie S1). DLS corroborated these observations, showing a continuous increase in particle size over time (Figure S7). Fluorescence recovery after photobleaching (FRAP) confirmed their liquid-like behavior, with recovery reaching approximately up to ∼90% within 2 min, consistent with previously reported peptide-based systems (Figure g). , Their dynamic properties were further supported by partitioning experiments, in which sulforhodamine B and chymotrypsin-FITC (CT-FITC) readily partitioned into the liquid droplets (Figure S8). Finally, NaCl, urea, and 1,6-hexanediol screens identified charge–charge interactions and hydrogen bonding rather than hydrophobic interactions as key driving forces for complex coacervation (Figure S9). Collectively, these results establish charge–charge interactions, hydrogen bonding, and multivalent polymeric counterions as the principal determinants of stable complex coacervation in this system.

Concentration-, Time-, and Gly-Arg-Dependent Intracellular LLPS

After examining potential interaction partners in vitro, we next traced cellular peptide uptake and intracellular droplet formation (Figure a). A549 human lung adenocarcinoma cells were incubated with varying amounts of Fmoc-R 3 TPP + Coum-R 3 TPP (total peptide concentrations: 125 μM, 250 μM, and 500 μM) using a coincubation approach for visualization. In this design, only the concentration of Fmoc-R 3 TPP was varied, while the concentration of Coum-R 3 TPP was maintained at a constant concentration of 20 μM. The coassembly was chosen as droplets formed by RNA and Coum-R 3 TPP self-quenched due to high fluorophore concentrations inside the complex coacervates, potentially interfering with accurate data interpretation of complex coacervates formed by Coum-R 3 TPP alone (Figure S10). Intracellular coumarin fluorescence appeared in a dose-and time-dependent manner. While negligible signals were detected at 125 μM, cells treated with 250 μM or 500 μM of Fmoc-R 3 TPP /Coum-R 3 TPP displayed detectable fluorescence after approximately 30 and 1 min, respectively (Figure b). Interestingly, despite the presence of the typical mitochondria-targeting moiety TPP, fluorescence accumulation occurred predominantly in the nuclear and perinuclear regions rather than in mitochondria, demonstrating an intracellular transport override by the Arg-rich peptide (Figure c). This observation is in agreement with a previous study that described the insufficient mitochondrial targeting properties of single TPP-containing peptides and studies that observed the nuclear targeting capabilities of Arg-rich sequences. , Furthermore, this localization is consistent with the stronger affinity of Fmoc-R3 TPP for RNA compared to ATP observed in vitro, which favors coacervation in RNA-rich nuclear environments (Figures d,e and S5).

3.

3

Peptide-driven intracellular complex coacervation. (a) Co-incubated Fmoc-R 3 TPP /Coum-R 3 TPP soluble monomers enter A549 cells and form complex coacervates in RNA-rich nuclear regions, consistent with nucleolar accumulation. (b) Time-dependent CLSM studies with varying Fmoc-R 3 TPP concentrations (480 μM, 230 μM, 105 μM) while maintaining Coum-R 3 TPP at a constant concentration of 20 μM. Cells were fixed prior to imaging. Coumarin fluorescence is shown in cyan, and the corresponding regions of interest (ROIs) are displayed as bright-field overlays on the right. (c) CLSM analysis of living cells. MitoTracker (red) costaining experiment (left) and the corresponding normalized fluorescence intensity profile along the dashed line (right). Total peptide concentration: 250 μM after 2 h of incubation. Experiments were performed in FBS-free DMEM. (d) Structure–function relationship through variations in Gly–Arg repeats and pendant π-block groups. (e) In cellulo intracellular complex coacervation propensity (left) and in vitro optical density (at 600 nm) of 0.1 mM Acet-R 3 TPP , Fmoc-R 2 TPP , Fmoc-R 3 TPP , Fmoc-R 4 TPP , and Fmoc-R 3 NH2 in the presence of 0.25 mM polyU. Standard deviations represent error bars of n = 3 replicas.

Having established a preliminary understanding of the forces driving nucleolar complex coacervation, several Fmoc-R 3 TPP derivatives were introduced to establish a structure–function relationship. Specifically, these derivatives were designed to elucidate the impact of (i) the N-terminal Fmoc moiety, (ii) the number of Gly–Arg repeats, and (iii) the TPP side chain on droplet formation propensity in vitro and in cellulo (Figures d and S1). To assess (i) the role of the N-terminal Fmoc, the acetylated version Ac–K­(TPP)­RGRGR-CONH2 (Acet-R 3 TPP ) was introduced. Replacing the Fmoc by its acetylated version shifted the phase diagram in the presence of polyU significantly toward higher peptide concentrations, indicating that the π-character is crucial for complex coacervation (Figures e and S11a). This becomes particularly evident in the cellular context, where complex coacervation was completely absent even when incubated at 500 μΜ Acet-R 3 TPP /Coum-R 3 TPP for 6 h (Figures e and S12). Next, Fmoc-K­(TPP)­RGR-CONH2 = Fmoc-R 2 TPP and Fmoc-K­(TPP)­RGRGRGR-CONH2 = Fmoc-R 4 TPP were synthesized to examine (ii) the impact of the number of Gly–Arg repeats (Figures d and S1). In vitro, the polyU-dependent phase diagram revealed a strong correlation between droplet formation propensity and number of Gly–Arg repeats, particularly in the low peptide/RNA concentration regime (Figures c and S11b,c). In cellulo, this correlation remained consistent, as nucleolar complex coacervation was observed only for Fmoc-R 3 TPP and Fmoc-R 4 TPP , while Fmoc-R 2 TPP samples showed no evidence of coacervation (Figures e and S12). As a control experiment, to exclude simple nuclear partitioning of the peptide material as the origin of the fluorescence signal, the coassembling peptide 20 μM Coum-R 3 TPP was investigated, which alone showed no localized signal enrichment (Figure S13). Lastly, (iii) the role of the TPP side chain was investigated by synthesizing the TPP-lacking derivative Fmoc-K­(NH2)­RGRGR-CONH2 = Fmoc-R 3 NH2 (Figure S1). As similarly observed for the acetylated version Acet-R 3 TPP , omitting the π-block on the side chain would shift the phase diagram toward higher peptide concentrations (Figures c and S11d). This is also reflected in cellulo, where no significant signals were detected after 6 h of incubation at 500 μΜ Fmoc-R 3 NH2 /Coum-R 3 TPP (Figures e and S12).

These data collectively demonstrate that intranuclear complex coacervation requires (i) an N-terminal Fmoc group, (ii) at least two Gly–Arg repeats, and (iii) the TPP side chain, owing to effective nucleolar peptide concentration governed by the number of Arg residues and droplet formation propensity determined by both π-character and charge (Figure d,e). These trends align well with a previous in-cell NMR study that points out the stickiness of poly-Arg peptides in E. coli as potential drivers for macromolecular assembly.

Subcellular Localization, Distribution, and Cellular Response

Having established the correlation between the in vitro droplet-forming propensity and intranuclear LLPS, we proceeded to further elucidate the subcellular localization and impact on cellular function (Figure a). Inside the nucleus, the nucleolus constitutes the largest and most prominent membrane-less organelle, where RNA accumulates as a result of ribosomal biogenesis, rRNA transcription, and processing. This property enriches nucleic acids into densely packed granules inside the nucleolar microenvironment. Co-staining with the RNA-specific dye SYTO showed that Fmoc-R 3 TPP /Coum-R 3 TPP accumulates in cellular regions enriched in RNA, consistent with nucleolar localization as similarly observed for Arg-rich peptide sequences (Figure b). As the complex coacervates form within the nucleolus, their shapes do not appear perfectly spherical (Figure b). Moreover, turbidity measurements using cell lysate showed no significant increase in optical density upon exposure to Fmoc-R 3 TPP , indicating that (i) nonspecific binding to cytosolic nucleic acids is negligible and (ii) the induction of complex coacervation is reserved for RNA-dense conditions, which are governed by the effective local concentrations of both the peptide and counterions (Figure S14).

4.

4

Subcellular localization and cellular response to intranuclear complex coacervation. (a) Monomers of Fmoc-R 3 TPP /Fmoc-R 3 TPP readily enter viable A549 cells, infiltrating the nucleolus to drive complex coacervation in the presence of densely packed RNA. As time proceeds, the in situ LLPS prompts apoptosis. (b) CLSM live-cell costaining experiments with Coumarin (cyan), SYTO (magenta), and MitoTracker (red). Normalized fluorescence is quantified along the dotted line. [Fmoc-R 3 TPP ] = 230 μM, [Coum-R 3 TPP ] = 20 μM after 2 h of incubation. (c) 3D representation of phalloidin (yellow) and Coumarin (cyan) of fixed and costained cells. [Fmoc-R 3 TPP ] = 230 μM, [Coum-R 3 TPP ] = 20 μM after 2 h of incubation. (d) Time-dependent resazurin-based metabolic assay with varying [Fmoc-R 3 TPP ], DMEM-treated negative control, and DMSO-treated positive control. Error bars represent standard deviations from n = 6 replicas. (e) Oxygen consumption rate (OCR) of A549 cells treated with varying concentrations of Fmoc-R 3 TPP . Prior to peptide addition, the OCR is set as 100% as a reference. Error bars represent standard errors of the mean (SEM) from at least n = 3 replicas. (f) Mito stress assay of Fmoc-R 3 TPP -treated A549 cells (labels are in accordance with (e) with electron transport chain modulators. After ATP synthase inhibition (oligomycin), FCCP disrupts the mitochondrial membrane potential. Rotenone and antimycin A then inhibit complexes I and III of the electron transport chain. Error bars represent standard errors of the mean (SEM) from at least n = 3 replicas. All experiments were conducted in FBS-free DMEM.

To elucidate the uptake mechanism, peptide-treated cells were incubated at 4 °C. Notably, this condition did not efficiently inhibit peptide uptake as evidenced by complex coacervation at 500 μM Fmoc-R 3 TPP /Coum-R 3 TPP after 2 h of incubation (Figure S15). This data in combination with the observed almost instantaneous complex coacervation hints toward an ATP-independent uptake mechanism as described by other Arg-rich systems. Next, the impact of intranuclear complex coacervation on cellular metabolic rate and viability was assessed. Co-staining experiments with Phalloidin, Propidium Iodide (PI), and MitoTracker revealed preserved cellular morphology and viability-associated features at the emergence of complex coacervation, as indicated by an intact actin cytoskeleton, mitochondria, and cell shape (Figures b,c and S16). However, as time proceeded, enhanced cell membrane permeability, cell rounding, and the presence of cell debris suggested progressive loss of viability upon prolonged exposure (Figures b and S17a–c). Moreover, the initially localized coumarin signal in the nucleolus gradually distributes throughout the whole cell, which is not only accompanied by nuclear fragmentation but also consistent with membrane permeabilization and loss of compartmental integrity during cell death (Figures b and S17d,e).

We performed a resazurin-based metabolic activity assay with varying concentrations of Fmoc-R 3 TPP to assess cellular metabolic activity in peptide-treated cells in bulk (Figure d). Whereas the metabolic activity at 125 μM was similar to that of DMEM-treated negative controls, it was critically impaired at peptide concentrations >250 μM (Figures d and S18a). Additionally, the metabolic activity of Fmoc-R 4 TPP -treated cells decreased even further, while cells subjected to the negative control peptides Acet-R 3 TPP , Fmoc-R 2 TPP , or Fmoc-R 3 NH2 were negligibly affected after 6 h of incubation at 500 μM (Figure S18b–d). These data further support that the biological impact is specifically associated with complex coacervation rather than peptide exposure alone.

We additionally conducted extracellular flux analyses of mitochondrial function to measure the oxygen consumption rate (OCR) and gain further insights into cellular respiration. In line with the resazurin assay, the OCR similarly showed Fmoc-R 3 TPP concentration dependency (Figure e). Whereas cells treated with 125 μM Fmoc-R 3 TPP exhibited an OCR of 103.4 ± 8.8% after approximately 11 h, it drastically dropped to 54.1 ± 6.8% and 0.7 ± 0.5%, respectively, when 500 μM or 2500 μM was applied instead (Figure e). A mito stress test was performed to elucidate the impact of complex coacervation on ATP production and spare respiratory capacity (Figure f). Upon treatment with electron transport chain modulators, samples at 500 μM and 2500 μM showed a decrease in both parameters, suggesting gradual mitochondrial dysfunction leading to cell death (Figure f).

Next, we introduced Annexin-V to ascertain the downstream pathway as a consequence of mitochondrial dysfunction. The protein binds to phosphatidylserine located on the external leaflet of the membrane when cells undergo apoptosis. In the presence of Annexin V-FITC, cells displayed clear membrane-associated signals already at the onset of coacervate formation (1 min at 500 μM Fmoc-1 TPP ) (Figure S19a). Thus, apoptotic signaling appears to be initiated rapidly even while gross cellular morphology remains initially preserved. Prolonging the incubation time to 1 h further enriched PI in the nuclear region, supporting progression from early apoptotic features toward loss of membrane integrity at later stages (Figure S19a). The protein profiler immunoassay revealed expression changes in Bcl-2, Survivin, TNF, HSP 27, TRAIL, and p27 at 1 h, suggesting multiple apoptotic pathways are affected on a systemic level (Figure S19b).

Together, these data link sustained intranuclear complex coacervation to mitochondrial dysfunction, metabolic collapse, and apoptosis-associated cell death.

Dynamic Persistence and Reversibility of Intranuclear Complex Coacervation

Liquid condensates are highly dynamic assemblies in which constituent molecules (proteins/RNA) continuously and rapidly exchange with the surrounding dilute (bulk) phase. Moreover, many of these assemblies are coupled to energy fluxes that sustain their liquid state and thereby enable transient signaling and regulation. , To probe whether the nucleolar complex coacervates formed by Fmoc-R 3 TPP share these dynamic characteristics, we conducted live-cell FRAP experiments. To prevent the continuous influx of peptide monomers, the dynamics were first examined under substrate-depleted conditions in which 1 min treatment with 500 μM Fmoc-R 3 TPP /Coum-R 3 TPP was followed by a medium exchange procedure (Figure a). Notably, the fluorescence signal recovered within approximately 6 s after bleaching, supporting the liquid-like behavior (Figure b,c). Under substrate-depleted conditions, the overall fluorescence intensity decreased to 78.5 ± 1.5% in the absence of bleach-point correction, indicating that peptide replenishment from the surrounding medium was strongly limited (Figure c). Consistent with this interpretation, CLSM live-cell imaging of cells treated with 500 μM Fmoc-R 3 TPP /Coum-R 3 TPP under the same substrate-depleted conditions further corroborated the dynamic behavior of the droplets (Figure d,e). Initially, prominent intranuclear droplets and cell blebbing (white arrows) were detected, suggesting that the onset of coacervation-induced stress is accompanied by transient detachment of the actin cortex from the plasma membrane (Figure d).

5.

5

Droplet dynamics and cell recovery under substrate-depleted conditions. (a) In-cell FRAP experiments including a medium exchange step. (b) Representative live-cell images of A549 cells, which undergo the FRAP procedure. [Fmoc-R 3 TPP ] = 480 μM, [Coum-R 3 TPP ] = 20 μM. (c) FRAP recovery curves of peptide-treated A549 cells under substrate-depleted conditions. Error bars (too small to visualize) represent standard deviations from n = 6 replicas. (d) Recovery experiments where cells are first treated for 1 min with [Fmoc-R 3 TPP ] = 480 μM, [Coum-R 3 TPP ] = 20 μM, which readily prompts LLPS inside the nucleolus. The stress component triggers cell blebbing, which can be recovered by medium exchange within a time frame of 5 h. (e) Time-dependent CLSM of cells after treatment and media exchange. White and black arrows highlight cell blebbing and a change in nuclear morphology, respectively. (f) Quantification of nucleolar Coumarin signal over time after medium exchange. The average of n = 3 droplets from two cells is fitted and depicted as a black line. All experiments were conducted in FBS-free DMEM.

However, the localized intracellular droplet signal diminished over time (at ∼60 min), after which cells gradually recovered a viable morphology within 5 h, as evidenced by changes in refractive index and re-establishment of cellular adhesion and spreading (Figure e,f). Moreover, morphological changes of the nuclear region (black arrows) suggested intracellular reorganization following compound treatment and droplet dissolution (Figure e). From this point onward, cells that had eliminated the peptide resumed division, indicating the restoration of biological function (Figure S20). These observations were further substantiated by cell viability measurements. Cells treated with 500 μM Fmoc-R 3 TPP for 24 h exhibited a viability of 17.0 ± 12.0%. In stark contrast, applying the medium exchange protocol restored cellular viability to 79.6 ± 7.7% after 24 h, further emphasizing that peptide removal under substrate-depleted conditions enables droplet dissolution and cellular recovery (Figure S21).

Intrigued by this reversibility, we next examined the system under substrate-sustained, steady-state conditions (Figure a). Using the same FRAP parameters as under substrate depletion (Figure a–c), fluorescence recovery increased to 98.6 ± 11.8% after 50 s, indicating continued exchange of the peptide material within the nucleolar complex coacervates when the extracellular peptide remained available (Figure a–c). To further assess the extent of this dynamic behavior, the same cell was subjected to multiple rounds of FRAP (Figure d). The fluorescence signal recovered over as many as six cycles without showing significant loss of recovery amplitude, showing that complex coacervates can be maintained dynamically as long as peptide supply is sustained (Figures d and c).

6.

6

Droplet dynamics under steady-state conditions. (a) In-cell FRAP experiments under substrate-abundant (steady-state) conditions. (b) Representative FRAP live-cell images of A549 cells treated with [Fmoc-R 3 TPP ] = 480 μM, [Coum-R 3 TPP ] = 20 μM. (c) FRAP recovery curves of peptide-treated A549 cells. Error bars represent standard deviations from n = 9 replicas (d). Repeated FRAP cycles on a single droplet in peptide-treated A549 cells. The same experimental conditions were applied as in (a). All experiments were conducted in FBS-free DMEM.

Together, these results define a reversible intracellular coacervation window in which nucleolar complex coacervates persist dynamically under continued peptide supply but dissolve upon substrate depletion, thereby allowing for recovery of cellular function.

Conclusions

We have shown that short cationic peptides can form complex coacervates inside living cells through preferential interactions with endogenous polyanionic biomolecules. Rather than being governed primarily by the installed targeting motif, subcellular localization is redirected by the Arg-rich nature of the peptide and intracellular interaction landscape, leading to selective enrichment of liquid-like complex coacervates in RNA-rich nucleolar regions. In this way, the present system establishes a targeting principle based not only on molecular ligands but also on the spatial distribution of endogenous biopolymers within the cell. Importantly, the resulting assemblies are dynamic, transient, and reversible and therefore more closely resemble native cellular condensates than previously reported intracellular peptide assemblies that culminate in persistent fiber formation or irreversible stress states. By distinguishing substrate-sustained coacervate persistence from substrate-depleted dissolution and recovery, this work further identifies a reversible regime in which intracellular complex coacervates can be installed, maintained temporarily, and subsequently removed. This nonequilibrium steady state is maintained by a constant turnover of peptide monomers, which the cell can withstand only for a limited time before undergoing apoptosis (Figure S22). These findings establish minimal synthetic peptides as context-responsive building blocks for intracellular coacervates and provide a conceptual foundation for future strategies in reversible compartment engineering, transient metabolic modulation, and the creation of synthetic reaction spaces that operate in direct exchange with living cellular environments.

Supplementary Material

ja6c06046_si_001.pdf (20.7MB, pdf)
Download video file (194.4KB, mp4)

Acknowledgments

For financial support, M.S., E.K., L.D.O., M.G.B., H.C.N., A.L., J.B., D.Y.W.N., and T.W. are thankful to the Max Planck Society. This research was conducted within the Max Planck School Matter to Life, supported by the Dieter Schwarz Foundation in collaboration with the Max Planck Society. The authors thank Dr. Sandra Ritz and Dr. Márton Gelléri from the Institute of Molecular Biology, Mainz, for their expertise in FRAP measurements. The authors thank Dr. Konrad Maxeiner from the Max Planck Institute for Polymer Research, Mainz, for his support in extracellular flux experiments. The authors gratefully acknowledge financial support from the Max Planck Society, the Max Planck-Bristol Centre for Minimal Biology, as well as the Deutsche Forschungsgemeinschaft (DFG), project: SFB 1551 – R04 (Projektnummer: 464588647).

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.6c06046.

  • Additional description of methods and supplementary data showing LCMS data of all synthesized peptides; control experiments including turbidity assays of Fmoc-R 3 TPP with ATP or individual components; supplementary droplet stability assays and ITC data; assays to determine level of unspecific binding and cellular uptake mechanism; phase diagrams, confocal imaging, and cell cytotoxicity assays for control peptides; and cell apoptosis assays and cell recovery studies after peptide removal (PDF)

  • Time-lapse imaging and coalescence of complex coacervates (MP4)

Open access funded by Max Planck Society.

The authors declare no competing financial interest.

References

  1. Li Y., Liu Y., Yu X. Y., Xu Y., Pan X., Sun Y., Wang Y., Song Y. H., Shen Z.. Membraneless Organelles in Health and Disease: Exploring the Molecular Basis, Physiological Roles and Pathological Implications. Signal Transduction Targeted Ther. 2024;9(1):305. doi: 10.1038/s41392-024-02013-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Liu J., Zhorabek F., Chau Y.. Biomaterial Design Inspired by Membraneless Organelles. Matter. 2022;5(9):2787–2812. doi: 10.1016/j.matt.2022.07.001. [DOI] [Google Scholar]
  3. Lo S. J., Lee C. C., Lai H. J.. The Nucleolus: Reviewing Oldies to Have New Understandings. Cell Res. 2006;16(6):530–538. doi: 10.1038/sj.cr.7310070. [DOI] [PubMed] [Google Scholar]
  4. Sun Y., Wu X., Li J., Radiom M., Mezzenga R., Verma C. S., Yu J., Miserez A.. Phase-Separating Peptide Coacervates with Programmable Material Properties for Universal Intracellular Delivery of Macromolecules. Nat. Commun. 2024;15(1):10094. doi: 10.1038/s41467-024-54463-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cerrato C. P., Krkoška M., Sun Y., Liaño-Pons J., Neo Q. Y., Vosselman T., Alzrigat M., Vojtěšek B., Lane D. P., Arsenian Henriksson M., Miserez A., Landreh M.. Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor OmoMYC. Mol. Pharmaceutics. 2025;22(6):3479–3490. doi: 10.1021/acs.molpharmaceut.5c00468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Tu W., Theisen R. Q., Jin P., Chenoweth D. M., Patel A. J., Good M. C.. Delivery of Peptide Coacervates to Form Stable Interaction Hubs in Cells. Nat. Commun. 2026;17:2250. doi: 10.1038/s41467-026-68793-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sun Y., Wu X., Shen K., Guo K., Lim D. S., Chew W. L., Yu J., Miserez A.. Polyethylene-Glycol-Conjugated Coacervates with Tunable Size for Intracellular MRNA Delivery. ACS Nano. 2025;19(27):24724–24735. doi: 10.1021/acsnano.4c16908. [DOI] [PubMed] [Google Scholar]
  8. Hilditch A. T., Romanyuk A., Cross S. J., Obexer R., McManus J. J., Woolfson D. N.. Assembling Membraneless Organelles from de Novo Designed Proteins. Nat. Chem. 2024;16(1):89–97. doi: 10.1038/s41557-023-01321-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Yeong V., Wang J. W., Horn J. M., Obermeyer A. C.. Intracellular Phase Separation of Globular Proteins Facilitated by Short Cationic Peptides. Nat. Commun. 2022;13(1):7882. doi: 10.1038/s41467-022-35529-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wang J., Hu L., Zhang H., Fang Y., Wang T., Wang H.. Intracellular Condensates of Oligopeptide for Targeting Lysosome and Addressing Multiple Drug Resistance of Cancer. Adv. Mater. 2022;34(1):2104704. doi: 10.1002/adma.202104704. [DOI] [PubMed] [Google Scholar]
  11. Wang W., Wang H., Zhang Z., Liu X., Hu B., Tian F., Ye Z., Shi L., Yu Z.. In Situ Liquid-Liquid Phase Separation of Peptides Into Droplets Targeting Membraneless Organelles for Enhanced Cancer Chemotherapy. Adv. Mater. 2025;37(28):2420399. doi: 10.1002/ADMA.202420399. [DOI] [PubMed] [Google Scholar]
  12. Mondal M., Swetman W. S., Karim S. U., Shrestha S., Davis A. M., Bai F., Huang F., Clemons T. D., Rangachari V.. Disulfide Cross-Linked Redox-Sensitive Peptide Condensates Are Efficient Cell Delivery Vehicles of Molecular Cargo. Proc. Natl. Acad. Sci. U. S. A. 2025;122(41):e2515427122. doi: 10.1073/pnas.2515427122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sun Y., Lau S. Y., Lim Z. W., Chang S. C., Ghadessy F., Partridge A., Miserez A.. Phase-Separating Peptides for Direct Cytosolic Delivery and Redox-Activated Release of Macromolecular Therapeutics. Nat. Chem. 2022;14(3):274–283. doi: 10.1038/s41557-021-00854-4. [DOI] [PubMed] [Google Scholar]
  14. Shebanova A., Perrin Q. M., Zhu K., Gudlur S., Chen Z., Sun Y., Huang C., Lim Z. W., Mondarte E. A., Sun R., Lim S., Yu J., Miao Y., Parikh A. N., Ludwig A., Miserez A.. Cellular Uptake of Phase-Separating Peptide Coacervates. Adv. Sci. 2024;11(42):2402652. doi: 10.1002/advs.202402652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ramšak M., Ramirez D. A., Hough L. E., Shirts M. R., Vidmar S., Eleršič Filipič K., Anderluh G., Jerala R.. Programmable de Novo Designed Coiled Coil-Mediated Phase Separation in Mammalian Cells. Nat. Commun. 2023;14(1):7973. doi: 10.1038/s41467-023-43742-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pieszka M., Han S., Volkmann C., Graf R., Lieberwirth I., Landfester K., Ng D. Y. W., Weil T.. Controlled Supramolecular Assembly Inside Living Cells by Sequential Multistaged Chemical Reactions. J. Am. Chem. Soc. 2020;142(37):15780–15789. doi: 10.1021/jacs.0c05261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ren Y., Zhou Z., Harley I., Aydin O. ¨., Driehaus-Ortiz L., Kaltbeitzel A., Xing J., Maxeiner K., Lieberwirth I., Landfester K., Ng D. Y. W., Weil T.. Intracellular Assembly of Supramolecular Peptide Nanostructures Controlled by Visible Light. Nat. Synth. 2025;4(6):673–683. doi: 10.1038/s44160-025-00751-5. [DOI] [Google Scholar]
  18. Chagri S., Maxeiner K., Silva M. J. S. A., Förch L., Link J., Roth P., Meyer R., Fetzer J., Kaltbeitzel A., Lieberwirth I., Landfester K., Wagner M., Ng D. Y. W., Weil T.. Intracellular Formation of Synthetic Peptide Nanostructures Causes Mitochondrial Disruption and Cell Death in Tumor Spheroids. Adv. Sci. 2025;12(25):2412606. doi: 10.1002/advs.202412606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Link J., Burg L., Chagri S., Nguyen H. C., Ng D. Y. W., Ravoo B. J., Weil T.. Photoswitchable Peptides as Molecular Tools to Encode Structural Order and Disorder in Intracellular Assemblies. Angew. Chem., Int. Ed. 2026;65(3):e14781. doi: 10.1002/anie.202514781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wang H., Song Y., Wang W., Chen N., Hu B., Liu X., Zhang Z., Yu Z.. Organelle-Mediated Self-Assembly of Peptides in Living Cells. J. Am. Chem. Soc. 2024;146(1):330–341. doi: 10.1021/jacs.3c09202. [DOI] [PubMed] [Google Scholar]
  21. Sun M., Wang C., Lv M., Fan Z., Du J.. Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma. J. Am. Chem. Soc. 2022;144(16):7337–7345. doi: 10.1021/jacs.2c00697. [DOI] [PubMed] [Google Scholar]
  22. Liu X., Li M., Liu J., Song Y., Hu B., Wu C., Liu A. A., Zhou H., Long J., Shi L., Yu Z.. In Situ Self-Sorting Peptide Assemblies in Living Cells for Simultaneous Organelle Targeting. J. Am. Chem. Soc. 2022;144(21):9312–9323. doi: 10.1021/jacs.2c01025. [DOI] [PubMed] [Google Scholar]
  23. Yamamoto S., Nishimura K., Morita K., Kanemitsu S., Nishida Y., Morimoto T., Aoi T., Tamura A., Maruyama T.. Microenvironment PH-Induced Selective Cell Death for Potential Cancer Therapy Using Nanofibrous Self-Assembly of a Peptide Amphiphile. Biomacromolecules. 2021;22(6):2524–2531. doi: 10.1021/acs.biomac.1c00267. [DOI] [PubMed] [Google Scholar]
  24. Chagri S., Ng D. Y. W., Weil T.. Designing Bioresponsive Nanomaterials for Intracellular Self-Assembly. Nat. Rev. Chem. 2022;6(5):320–338. doi: 10.1038/s41570-022-00373-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chagri Ms. S., Burgstaller Ms. A., Schirra Dr. C., Link Mr. J., Zhou P. Z., Roth Mr. P., Meyer Mr. R., Fetzer Ms. J., Ren Mr. Y., Si Mr. S., Mazzotta Ms. F., Wagner Dr. M., Lieberwirth Dr. I., Landfester P. K., Ng Dr. D. Y. W., Staufer Dr. O., Weil P. T.. Intracellular peptide nanofibers enhance T cell fitness and anti-cancer activity. ChemRxiv. 2026 doi: 10.26434/CHEMRXIV-2024-3LXGK. [DOI] [Google Scholar]
  26. Zhou Z., Maxeiner K., Moscariello P., Xiang S., Wu Y., Ren Y., Whitfield C. J., Xu L., Kaltbeitzel A., Han S., Mücke D., Qi H., Wagner M., Kaiser U., Landfester K., Lieberwirth I., Ng D. Y. W., Weil T.. In Situ Assembly of Platinum­(II)-Metallopeptide Nanostructures Disrupts Energy Homeostasis and Cellular Metabolism. J. Am. Chem. Soc. 2022;144(27):12219–12228. doi: 10.1021/jacs.2c03215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Donau C., Späth F., Sosson M., Kriebisch B. A. K., Schnitter F., Tena-Solsona M., Kang H. S., Salibi E., Sattler M., Mutschler H., Boekhoven J.. Active Coacervate Droplets as a Model for Membraneless Organelles and Protocells. Nat. Commun. 2020;11(1):1–10. doi: 10.1038/s41467-020-18815-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wang J., Abbas M., Huang Y., Wang J., Li Y.. Redox-Responsive Peptide-Based Complex Coacervates as Delivery Vehicles with Controlled Release of Proteinous Drugs. Commun. Chem. 2023;6(1):243. doi: 10.1038/s42004-023-01044-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kamagata K., Hando A., Ariefai M., Iwaki N., Kanbayashi S., Koike R., Ikeda K.. Rational Design of Phase Separating Peptides Based on Phase Separating Protein Sequence of P53. Sci. Rep. 2023;13(1):5648. doi: 10.1038/s41598-023-32632-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Higashi, S. L. ; Hirosawa, K. M. ; Fujimoto, R. ; Kanemaru, K. ; Yoshida, N. ; Suzuki, K. G. N. ; Ikeda, M. . Sticker-Spacer Molecular Design Controls Coacervate Formation and Internal Microenvironments in low-molecular-weight Compounds; JACS Au, 2026. 10.1021/JACSAU.5C01238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Saha B., Chatterjee A., Reja A., Das D., Li R., Chemcomm, Communication C.. Condensates of Short Peptides and ATP for the Temporal Regulation of Cytochrome c Activity. Chem. Commun. 2019;55(94):14194–14197. doi: 10.1039/C9CC07358B. [DOI] [PubMed] [Google Scholar]
  32. Chagri S., Fetzer J., Roth P., Lahu A., Alleva N., Zhang J., Wagner M., Si S., Lieberwirth I., Landfester K., Ng D. Y. W., Weil T.. Programming Nanostructure Formation Through Furin-Triggered Isopeptide Conversion and Peptide Self-Assembly. Macromol. Biosci. 2026;26(1):e00427. doi: 10.1002/mabi.202500427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ghosh G., Kartha K. K., Fernández G.. Tuning the Mechanistic Pathways of Peptide Self-Assembly by Aromatic Interactions. Chem. Commun. 2021;57(13):1603–1606. doi: 10.1039/D0CC07199D. [DOI] [PubMed] [Google Scholar]
  34. Bergmann A. M., Bauermann J., Bartolucci G., Donau C., Stasi M., Holtmannspötter A.-L., Jülicher F., Weber C. A., Boekhoven J.. Liquid Spherical Shells Are a Non-Equilibrium Steady State of Active Droplets. Nat. Commun. 2023;14(1):1–12. doi: 10.1038/s41467-023-42344-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Alberti S., Gladfelter A., Mittag T.. Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates. Cell. 2019;176(3):419–434. doi: 10.1016/j.cell.2018.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rennick J. J., Nowell C. J., Pouton C. W., Johnston A. P. R.. Resolving Subcellular PH with a Quantitative Fluorescent Lifetime Biosensor. Nat. Commun. 2022;13(1):6023. doi: 10.1038/s41467-022-33348-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yuan H., Liu J., Xu R., Yang K., Qu R., Liu S., Zhang Y., Xiang M.. The Spatiotemporal Heterogeneity of Reactive Oxygen Species in the Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: A New Insight. Cell. Mol. Biol. Lett. 2025;30(1):70. doi: 10.1186/s11658-025-00745-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cao S., Ivanov T., Heuer J., Ferguson C. T. J., Landfester K., Caire da Silva L.. Dipeptide Coacervates as Artificial Membraneless Organelles for Bioorthogonal Catalysis. Nat. Commun. 2024;15(1):39. doi: 10.1038/s41467-023-44278-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sun Y., Wu X., Li J., Verma C. S., Yu J., Miserez A.. Peptide-Based Complex Coacervates Stabilized by Cation−π Interactions for Cell Engineering. J. Am. Chem. Soc. 2025;147(5):4284–4295. doi: 10.1021/jacs.4c14469. [DOI] [PubMed] [Google Scholar]
  40. Huang C., Gudlur S., Maricar S., Chen Z., Shebanova A., Sun Y., Saliba V., Xu C., Zou Y., Zhang J., Boujday S., Miserez A.. Peptide Coacervates as Intracellular Delivery Vehicles for Synergistic Cancer Photothermal- and Chemo-Therapies. APL Bioeng. 2025;9(3):036101. doi: 10.1063/5.0279643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Miki T., Hashimoto M., Takahashi H., Shimizu M., Nakayama S., Furuta T., Mihara H.. De Novo Designed YK Peptides Forming Reversible Amyloid for Synthetic Protein Condensates in Mammalian Cells. Nat. Commun. 2024;15(1):8503. doi: 10.1038/s41467-024-52708-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shapiro D. M., Deshpande S., Eghtesadi S. A., Zhong M., Fontes C. M., Fiflis D., Rohm D., Min J., Kaur T., Peng J., Ney M., Su J., Dai Y., Asokan A., Gersbach C. A., Chilkoti A.. Synthetic Biomolecular Condensates Enhance Translation from a Target MRNA in Living Cells. Nat. Chem. 2025;17(3):448–456. doi: 10.1038/s41557-024-01706-7. [DOI] [PubMed] [Google Scholar]
  43. Li Y., Xu T., Li Y., Wang H.. Enzyme Induced Solid-Like Condensates Formation of Engineered Peptide in Living Cells for Prostate Cancer Inhibition. Angew. Chem., Int. Ed. 2025;64(30):e202504958. doi: 10.1002/anie.202504958. [DOI] [PubMed] [Google Scholar]
  44. Smith J., Calidas D., Schmidt H., Lu T., Rasoloson D., Seydoux G.. Spatial Patterning of P Granules by RNA-Induced Phase Separation of the Intrinsically-Disordered Protein MEG-3. eLife. 2016;5(DECEMBER2016):e21337. doi: 10.7554/ELIFE.21337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zielonka J., Joseph J., Sikora A., Hardy M., Ouari O., Vasquez-Vivar J., Cheng G., Lopez M., Kalyanaraman B.. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem. Rev. 2017;117(15):10043. doi: 10.1021/acs.chemrev.7b00042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Chong P. A., Vernon R. M., Forman-Kay J. D.. RGG/RG Motif Regions in RNA Binding and Phase Separation. J. Mol. Biol. 2018;430(23):4650–4665. doi: 10.1016/j.jmb.2018.06.014. [DOI] [PubMed] [Google Scholar]
  47. Holtmannspötter A.-L., Machatzke C., Begemann C., Salibi E., Donau C., Späth F., Boekhoven J., Mutschler H.. Regulating Nucleic Acid Catalysis Using Active Droplets. Angew. Chem., Int. Ed. 2024;63(47):e202412534. doi: 10.1002/anie.202412534. [DOI] [PubMed] [Google Scholar]
  48. Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V. H., Janke A. M., Baatsen P., Vercruysse T., Kolaitis R. M., Daelemans D., Taylor J. P., Kedersha N., Anderson P., Impens F., Sobott F., Schymkowitz J., Rousseau F., Fawzi N. L., Robberecht W., Van Damme P., Tompa P., Van Den Bosch L.. Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics. Mol. Cell. 2017;65(6):1044–1055. doi: 10.1016/j.molcel.2017.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sathyavageeswaran A., Pandey P. K., Holmlund N., Kaushik P., McIntosh S., Mokdad R., Perry S. L.. Role of Charge Patterning and Hydrophobicity in Peptide-Based Complex Coacervates. Biomacromolecules. 2025;26(10):6574–6585. doi: 10.1021/acs.biomac.5c00773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Abbas M., Lipiński W. P., Nakashima K. K., Huck W. T. S., Spruijt E.. A Short Peptide Synthon for Liquid–Liquid Phase Separation. Nat. Chem. 2021;13(11):1046–1054. doi: 10.1038/s41557-021-00788-x. [DOI] [PubMed] [Google Scholar]
  51. Yang F., Liao Z., Yang G., Wang Y.. Comprehensive Regulation of Liquid-Liquid Phase Separation by Interplay of Electrostatic, Hydrophobic and Crowding Effects. J. Mol. Liq. 2025;437:128455. doi: 10.1016/j.molliq.2025.128455. [DOI] [Google Scholar]
  52. Aletras A., Barlos K., Gatos D., Koutsogianni S., Mamos P.. Preparation of the Very Acid-Sensitive Fmoc-Lys­(Mtt)-OH Application in the Synthesis of Side-Chain to Side-Chain Cyclic Peptides and Oligolysine Cores Suitable for the Solid-Phase Assembly of MAPs and TASPs. Int. J. Pept. Protein Res. 1995;45(5):488–496. doi: 10.1111/j.1399-3011.1995.tb01065.x. [DOI] [PubMed] [Google Scholar]
  53. Poudyal R. R., Pir Cakmak F., Keating C. D., Bevilacqua P. C.. Physical Principles and Extant Biology Reveal Roles for RNA-Containing Membraneless Compartments in Origins of Life Chemistry. Biochemistry. 2018;57(17):2509. doi: 10.1021/acs.biochem.8b00081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Poprawa S. M., Stasi M., Kriebisch B. A. K., Wenisch M., Sastre J., Boekhoven J.. Active Droplets through Enzyme-Free, Dynamic Phosphorylation. Nat. Commun. 2024;15(1):1–11. doi: 10.1038/s41467-024-48571-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Fisher R. S., Elbaum-Garfinkle S.. Tunable Multiphase Dynamics of Arginine and Lysine Liquid Condensates. Nat. Commun. 2020;11(1):4628. doi: 10.1038/s41467-020-18224-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Baruch Leshem A., Sloan-Dennison S., Massarano T., Ben-David S., Graham D., Faulds K., Gottlieb H. E., Chill J. H., Lampel A.. Biomolecular Condensates Formed by Designer Minimalistic Peptides. Nat. Commun. 2023;14(1):421. doi: 10.1038/s41467-023-36060-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Bae W., Yoon T. Y., Jeong C.. Direct Evaluation of Self-Quenching Behavior of Fluorophores at High Concentrations Using an Evanescent Field. PLoS One. 2021;16(2):e0247326. doi: 10.1371/journal.pone.0247326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Ji S., Li J., Duan X., Zhang J., Zhang Y., Song M., Li S., Chen H., Ding D.. Targeted Enrichment of Enzyme-Instructed Assemblies in Cancer Cell Lysosomes Turns Immunologically Cold Tumors Hot. Angew. Chem., Int. Ed. 2021;60(52):26994–27004. doi: 10.1002/anie.202110512. [DOI] [PubMed] [Google Scholar]
  59. Kyne C., Crowley P. B.. Short Arginine Motifs Drive Protein Stickiness in the Escherichia Coli Cytoplasm. Biochemistry. 2017;56(37):5026–5032. doi: 10.1021/acs.biochem.7b00731. [DOI] [PubMed] [Google Scholar]
  60. Sirri V., Urcuqui-Inchima S., Roussel P., Hernandez-Verdun D.. Nucleolus: The Fascinating Nuclear Body. Histochem. Cell Biol. 2008;129(1):13–31. doi: 10.1007/s00418-007-0359-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Selvi R. B., Chatterjee S., Jagadeesan D., Chaturbedy P., Suma B. S., Eswaramoorthy M., Kundu T. K.. ATP Driven Clathrin Dependent Entry of Carbon Nanospheres Prefer Cells with Glucose Receptors. J. Nanobiotechnology. 2012;10:35. doi: 10.1186/1477-3155-10-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Chithrani B. D., Chan W. C. W.. Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes. Nano Lett. 2007;7(6):1542–1550. doi: 10.1021/nl070363y. [DOI] [PubMed] [Google Scholar]
  63. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y.. Arginine-Rich Peptides: An Abundant Source Of Membrane-Permeable Peptides Having Potential As Carriers For Intracellular Protein Delivery. J. Biol. Chem. 2001;276(8):5836–5840. doi: 10.1074/jbc.M007540200. [DOI] [PubMed] [Google Scholar]
  64. Yewdall N. A., André A. A. M., Lu T., Spruijt E.. Coacervates as Models of Membraneless Organelles. Curr. Opin. Colloid Interface Sci. 2021;52:101416. doi: 10.1016/j.cocis.2020.101416. [DOI] [Google Scholar]
  65. Milin A. N., Deniz A. A.. Reentrant Phase Transitions and Non-Equilibrium Dynamics in Membraneless Organelles. Biochemistry. 2018;57(17):2470–2477. doi: 10.1021/acs.biochem.8b00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Charras G. T., Hu C. K., Coughlin M., Mitchison T. J.. Reassembly of Contractile Actin Cortex in Cell Blebs. J. Cell Biol. 2006;175(3):477–490. doi: 10.1083/jcb.200602085. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ja6c06046_si_001.pdf (20.7MB, pdf)
Download video file (194.4KB, mp4)

Articles from Journal of the American Chemical Society are provided here courtesy of American Chemical Society

RESOURCES